Unknown

Dataset Information

Liposomal Grb2 antisense oligodeoxynucleotide (BP1001) in patients with refractory or relapsed haematological malignancies: a single-centre, open-label, dose-escalation, phase 1/1b trial.


ABSTRACT:

SUBMITTER: Ohanian M 

PROVIDER: S-EPMC11840760 | biostudies-literature | 2018 Apr

REPOSITORIES: biostudies-literature